RA Capital Nexus Fund III, L.P.
Director; Director, 10% Owner · 18 filings · Latest: Jun 29, 2026
Artiva Biotherapeutics, Inc.
Bicara Therapeutics Inc.
Climb Bio, Inc.
Evommune, Inc.
Mineralys Therapeutics, Inc.
Parabilis Medicines, Inc.
Septerna, Inc.
Sionna Therapeutics, Inc.
SpyGlass Pharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SION | RA Capital Nexus Fund III, L.P. | — | Oct 24, 2025 | Proposed Sale | $39.21 | 66,672 | $2.6M | — |
← Previous
Page 2 of 2